Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,026
archived clinical trials in
Epilepsy

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Grand Rapids, MI
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Traverse City, MI
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Traverse City, MI
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Minneapolis, MN
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Chesterfield, MO
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Kansas City, MO
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
St. Louis, MO
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Las Vegas, NV
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Edison, NJ
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Edison, NJ
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
West Orange, NJ
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
West Orange, NJ
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
New York, NY
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Plainview, NY
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Plainview, NY
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Asheville, NC
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Asheville, NC
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Chapel Hill, NC
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Greenville, NC
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Greenville, NC
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Raleigh, NC
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Columbus, OH
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Oklahoma City, OK
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Cheswick, PA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Cheswick, PA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Greensburg, PA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Greensburg, PA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Philadelphia, PA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Dallas, TX
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Galveston, TX
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Galveston, TX
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Houston, TX
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
San Antonio, TX
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Wichita Falls, TX
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Salt Lake City, UT
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Richmond, VA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Richmond, VA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Seattle, WA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Milwaukee, WI
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Capital Federal,
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Capital Federal,
Click here to add this to my saved trials
Seizure Detection and Warning System in Epilepsy Patients
A Pivotal, Phase III Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients
Status: Enrolling
Updated:  1/4/2017
Jose' E. Cavazos
mi
from
San Antonio, TX
Seizure Detection and Warning System in Epilepsy Patients
A Pivotal, Phase III Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients
Status: Enrolling
Updated: 1/4/2017
Jose' E. Cavazos
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Health Economic Study Evaluating the Brain Sentinel® GTC Seizure Detection and Information Systems Impact on Epilepsy and Healthcare Utilization
A Health Economic Study Evaluating the Brain Sentinel® GTC Seizure Detection and Information Systems Impact on Epilepsy and Healthcare Utilization
Status: Enrolling
Updated:  1/4/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
A Health Economic Study Evaluating the Brain Sentinel® GTC Seizure Detection and Information Systems Impact on Epilepsy and Healthcare Utilization
A Health Economic Study Evaluating the Brain Sentinel® GTC Seizure Detection and Information Systems Impact on Epilepsy and Healthcare Utilization
Status: Enrolling
Updated: 1/4/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Mobile, AL
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Mobile, AL
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Tucson, AZ
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Jonesboro, AR
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Little Rock, AR
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Los Angeles, CA
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Stanford, CA
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Stanford, CA
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Denver, CO
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Washington,
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Washington,
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Jacksonville, FL
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Miami, FL
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Orlando, FL
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Tallahassee, FL
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Tampa, FL
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Atlanta, GA
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Augusta, GA
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Augusta, GA
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Lexington, KY
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Lexington, KY
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
St. Paul, MN
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
St. Paul, MN
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Columbia, MO
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Columbia, MO
Click here to add this to my saved trials